Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
John Edwards is a licensed attorney with experience in commodities and investments. He provides performance analysis of hedge funds and investors. An LLC offers flexibility in management and tax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results